Bright Minds Biosciences (DRUG) Institutional Ownership $32.01 -0.40 (-1.23%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)CurrentInstitutional OwnershipPercentage40.52%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$68.55MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$6.46M Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRUG Institutional Buying and Selling by Quarter Remove Ads Bright Minds Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049% 2/17/2025Millennium Management LLC40,379$1.45M0.0%N/A0.911% 2/17/2025Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485% 2/17/2025Bank of America Corp DE4,793$173K0.0%N/A0.108% 2/17/2025Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560% 2/14/2025RA Capital Management L.P.460,829$16.60M0.2%N/A10.402% 2/14/2025Jane Street Group LLC6,600$238K0.0%N/A0.149% 2/14/2025Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576% 2/14/2025AdvisorShares Investments LLC3,075$111K0.0%-98.3%0.069% 2/14/2025Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006% 2/14/2025Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991% 2/14/2025Vivo Capital LLC251,572$9.06M1.0%N/A5.679% 2/13/2025Walleye Capital LLC103,192$3.72M0.0%N/A2.327% 2/13/2025Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369% 2/13/2025Atika Capital Management LLC15,000$540K0.1%N/A0.339% 2/14/2024AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246% 11/6/2023AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452% 8/9/2023AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640% 5/9/2023AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553% 8/8/2022AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439% 5/9/2022AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745% 2/9/2022Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119% 1/31/2022AdvisorShares Investments LLC95,942$304K0.0%N/A0.810% (Data available from 1/1/2016 forward)Remove Ads DRUG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRUG shares? During the previous two years, 15 institutional investors and hedge funds held shares of Bright Minds Biosciences. The most heavily invested institutionals were Janus Henderson Group PLC ($18.39M), RA Capital Management L.P. ($16.60M), Vivo Capital LLC ($9.06M), Point72 Asset Management L.P. ($4.87M), Adage Capital Partners GP L.L.C. ($4.77M), Walleye Capital LLC ($3.72M), and Acuta Capital Partners LLC ($2.49M).Learn more on DRUG's institutional investors. What percentage of Bright Minds Biosciences stock is owned by institutional investors? 40.52% of Bright Minds Biosciences stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings. Which institutional investors have been buying Bright Minds Biosciences stock? Of the 15 institutional investors that purchased Bright Minds Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($508.78K), RA Capital Management L.P. ($460.83K), Vivo Capital LLC ($251.57K), AdvisorShares Investments LLC ($220.64K), Point72 Asset Management L.P. ($135.19K), Adage Capital Partners GP L.L.C. ($132.50K), and Walleye Capital LLC ($103.19K). How much institutional buying is happening at Bright Minds Biosciences? Institutional investors have bought a total of 2,123,635 shares in the last 24 months. This purchase volume represents approximately $69.06M in transactions. Which Bright Minds Biosciences major shareholders have been selling company stock? The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($526.73K). How much institutional selling is happening at Bright Minds Biosciences? Institutional investors have sold a total of 526,730 shares in the last 24 months. This volume of shares sold represents approximately $7.02M in transactions. Related Companies Structure Therapeutics Institutional Ownership 89bio Institutional Ownership Chimerix Institutional Ownership Avid Bioservices Institutional Ownership Arcus Biosciences Institutional Ownership Vir Biotechnology Institutional Ownership Mineralys Therapeutics Institutional Ownership Phibro Animal Health Institutional Ownership Spyre Therapeutics Institutional Ownership Nurix Therapeutics Institutional Ownership This page (NASDAQ:DRUG) was last updated on 4/16/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRUG Stock Free DRUG Stock Alerts